These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 170381)

  • 1. Effect of large doses of 131I-19-iodocholesterol on metapyralone-induced adrenal cortical hyperplasia in dogs.
    Anderson BG; Beierwaltes WH; Nishiyama RH; Ice RD
    J Nucl Med; 1975 Oct; 16(10):928-32. PubMed ID: 170381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Irradiation therapy with 131I-6beta-iodocholesterol of metapyralone induced adrenal hyperplasia in rats.
    Tragl KH; Kinast H; Hinterberger H; Angelberger P; Kletter K
    Res Exp Med (Berl); 1978 Mar; 172(2):137-41. PubMed ID: 644137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The diagnosis of Cushing's syndrome using 131I-19-iodocholesterol uptake and adrenal imaging.
    Ortega D; Foz M; Doménech-Torné FM; Tresánchez JM
    Clin Endocrinol (Oxf); 1980 Aug; 13(2):145-9. PubMed ID: 7438469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [131I-19-iodocholesterol adrenal scanning in Cushing's syndrome (author's transl)(proceedings)].
    Charbonnel B; Chatal JF; Chupin M; Guillon J
    Ann Endocrinol (Paris); 1976; 37(4):315-6. PubMed ID: 192129
    [No Abstract]   [Full Text] [Related]  

  • 5. [Adrenal scintigraphy using 131 I-19-iodocholesterol. Value in the exploration of Cushing's syndrome].
    Charbonnel B; Chatal JF; Chupin M; Guillon J
    Nouv Presse Med; 1976 Dec; 5(42):2861-6. PubMed ID: 995622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 131I-iodocholesterol (NP-59) scintigraphy in adrenocortical diseases.
    Taillefer R; Soucy JP; Eybalin MC; Levasseur A
    J Can Assoc Radiol; 1983 Jun; 34(2):120-4. PubMed ID: 6885882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new and superior adrenal scanning agent, NP-59.
    Sarkar SD; Beierwaltes H; Ice RD; Basmadjian GP; Hetzel KR; Kennedy WP; Mason MM
    J Nucl Med; 1975 Nov; 16(11):1038-42. PubMed ID: 1185265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adrenal Size and function after irradiation with 131I-6 beta-Iodocholesterol in rabbits.
    Tragl KH; Kinast H; Angelberger P; Hruby H; Steininger H; Kletter K; Dragosics B
    Res Exp Med (Berl); 1981; 179(3):215-21. PubMed ID: 6275474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathophysiology of Cushing's disease.
    Fehm HL; Voigt KH
    Pathobiol Annu; 1979; 9():225-55. PubMed ID: 225710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful adrenal autotransplantation in Cushing's disease.
    Ott R; Calandra D; Prinz RA; Brooks MH; Lawrence AM; Paloyan E
    Surgery; 1984 Dec; 96(6):1054-60. PubMed ID: 6505958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acquired prolactin deficiency (APD) after treatment for Cushing's disease is a reliable marker of irreversible severe GHD but does not reflect disease status.
    Mukherjee A; Murray RD; Teasdale GM; Shalet SM
    Clin Endocrinol (Oxf); 2004 Apr; 60(4):476-83. PubMed ID: 15049963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adrenal scintigraphy with 131I-19-iodochlesterol in the diagnosis of Cushing's syndrome associated with adrenal tumor.
    Barliev GB
    Eur J Nucl Med; 1979 Dec; 4(6):449-51. PubMed ID: 520360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uptake of 131I-19-cholesterol by normal and spontaneously hyperfunctioning canine adrenals.
    van den Brom WE; Rijnberk A; Lubberink AA; de Bruijne JJ
    Eur J Nucl Med; 1979 Feb; 4(1):61-67. PubMed ID: 227690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of adrenalectomy in Cushing's syndrome.
    Sarkar R; Thompson NW; McLeod MK
    Surgery; 1990 Dec; 108(6):1079-84. PubMed ID: 2247833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 131I-19-iodocholesterol scintigraphy of the adrenal cortex.
    Dige-Petersen H; Munkner T; Fogh J; Blichert-Toft M; Lund JO
    Acta Endocrinol (Copenh); 1975 Sep; 80(1):81-94. PubMed ID: 1173986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adrenal localization in the adrenocorticotropic hormone-independent Cushing syndrome.
    Fig LM; Gross MD; Shapiro B; Ehrmann DA; Freitas JE; Schteingart DE; Glazer GM; Francis IR
    Ann Intern Med; 1988 Oct; 109(7):547-53. PubMed ID: 3421563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Dissociation between absorption of 131I-19-iodocholesterol and hormonal activity in corticosteroma patients].
    Burliev G; Koev D; Zlatareva N; Khubaveshki S
    Vutr Boles; 1987; 26(3):88-91. PubMed ID: 3617712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiocholesterol scintigraphy in Cushing's syndrome.
    Rufini V; Saletnich I; Troncone L
    Rays; 1992; 17(1):40-8. PubMed ID: 1636017
    [No Abstract]   [Full Text] [Related]  

  • 19. [Cushing's syndrome due to bilateral adrenal macronodular hyperplasia. From ACTH-dependent hypercortisolism to ACTH-independent hypercortisolism].
    López JM; Sapunar J; Donoso J; Martínez P
    Rev Med Chil; 1991 Oct; 119(10):1165-70. PubMed ID: 1668993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adrenocorticotropic hormone-independent Cushing's syndrome.
    Bourdeau I; Lampron A; Costa MH; Tadjine M; Lacroix A
    Curr Opin Endocrinol Diabetes Obes; 2007 Jun; 14(3):219-25. PubMed ID: 17940443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.